NCT07215429 is a clinical trial of No intervention in Pulse Oximetry, Oxygen Measurements, SpO2, sponsored by Philips Clinical & Medical Affairs Global.

Who is sponsoring NCT07215429?

NCT07215429 is sponsored by Philips Clinical & Medical Affairs Global.

What drugs are being tested in NCT07215429?

Interventions in NCT07215429: No intervention.

What condition does NCT07215429 study?

NCT07215429 studies Pulse Oximetry, Oxygen Measurements, SpO2.

Is NCT07215429 still recruiting?

NCT07215429 is currently terminated. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT07215429

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SpO2 Validation Study-Philips Optimus

Terminated Last updated 13 April 2026

What this trial tests

trial testing No intervention in Pulse Oximetry, Oxygen Measurements, SpO2 in 24 participants. Terminated before completion.

Timeline

9 September 2025

Primary endpoint
19 September 2025

19 September 2025

Quick facts

Lead sponsor	Philips Clinical & Medical Affairs Global
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	24
Start date	9 September 2025
Primary completion	19 September 2025
Estimated completion	19 September 2025
Sites	1 location across United States

Drugs / interventions tested

No intervention

Conditions studied

Pulse Oximetry, Oxygen Measurements, SpO2 — all drugs for Pulse Oximetry, Oxygen Measurements, SpO2 →

Sponsor

Philips Clinical & Medical Affairs Global — full company profile →

Who can join

Adults 18 to 50, any sex, with Pulse Oximetry, Oxygen Measurements, SpO2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Validation study to validate the SpO2 accuracy performance of the Sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other Philips Clinical & Medical Affairs Global trials

Trials by the same sponsor.

NCT07521735 — NEXT GEN - PHILIPS OPTIMUS · recruiting
NCT07368036 — MR 7700 Multinuclear Application Clinical Trial · NA · not yet recruiting
NCT07449715 — Respiration From Pleth Validation · recruiting
NCT07317479 — Clinical Study for P-MAR · not yet recruiting
NCT07317427 — Precise Image for Interventional CT · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07215429 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Philips Clinical & Medical Affairs Global
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07215429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing